These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19995363)

  • 21. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of obesity on outcomes in patients undergoing implantation of continuous-flow left ventricular assist devices.
    Volkovicher N; Kurihara C; Critsinelis A; Kawabori M; Sugiura T; Manon M; Civitello AB; Morgan JA
    J Artif Organs; 2018 Jun; 21(2):180-187. PubMed ID: 29372417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left ventricular assist device as 'bridge to weight loss' prior to transplantation in obese patients with advanced heart failure.
    Dhesi P; Simsir SA; Daneshvar D; Rafique A; Phan A; Schwarz ER
    Ann Transplant; 2011; 16(1):5-13. PubMed ID: 21436768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obese patients and mechanical circulatory support: weight loss, adverse events, and outcomes.
    Zahr F; Genovese E; Mathier M; Shullo M; Lockard K; Zomak R; McNamara D; Toyoda Y; Kormos RL; Teuteberg JJ
    Ann Thorac Surg; 2011 Oct; 92(4):1420-6. PubMed ID: 21958791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neurocognitive function in destination therapy patients receiving continuous-flow vs pulsatile-flow left ventricular assist device support.
    Petrucci RJ; Rogers JG; Blue L; Gallagher C; Russell SD; Dordunoo D; Jaski BE; Chillcott S; Sun B; Yanssens TL; Tatooles A; Koundakjian L; Farrar DJ; Slaughter MS
    J Heart Lung Transplant; 2012 Jan; 31(1):27-36. PubMed ID: 22153550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of body mass index and device type on infection in left ventricular assist device support beyond 30 days.
    Martin SI; Wellington L; Stevenson KB; Mangino JE; Sai-Sudhakar CB; Firstenberg MS; Blais D; Sun BC
    Interact Cardiovasc Thorac Surg; 2010 Jul; 11(1):20-3. PubMed ID: 20388700
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-transplant obesity in heart transplantation: are there predictors of worse outcomes?
    Macha M; Molina EJ; Franco M; Luyun L; Gaughan JP; McClurken JB; Furukawa S
    Scand Cardiovasc J; 2009; 43(5):304-10. PubMed ID: 19291586
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure.
    Dang NC; Topkara VK; Mercando M; Kay J; Kruger KH; Aboodi MS; Oz MC; Naka Y
    J Heart Lung Transplant; 2006 Jan; 25(1):1-6. PubMed ID: 16399523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index is a useful predictor of prognosis after left ventricular assist system implantation.
    Mano A; Fujita K; Uenomachi K; Kazama K; Katabuchi M; Wada K; Terakawa N; Arai K; Hori Y; Hashimoto S; Nakatani T; Kitamura S
    J Heart Lung Transplant; 2009 May; 28(5):428-33. PubMed ID: 19416769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patients with low compared with high body mass index gain more weight after implantation of a continuous-flow left ventricular assist device.
    Emani S; Brewer RJ; John R; Slaughter MS; Lanfear DE; Ravi Y; Sundareswaran KS; Farrar DJ; Sai-Sudhakar CB
    J Heart Lung Transplant; 2013 Jan; 32(1):31-5. PubMed ID: 23164534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of diabetes on short- and long-term outcomes after left ventricular assist device implantation.
    Topkara VK; Dang NC; Martens TP; Cheema FH; Liu JF; Liang LM; Cheema AF; Barili F; Oz MC; Naka Y
    J Heart Lung Transplant; 2005 Dec; 24(12):2048-53. PubMed ID: 16364848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Device exchange after primary left ventricular assist device implantation: indications and outcomes.
    Stulak JM; Cowger J; Haft JW; Romano MA; Aaronson KD; Pagani FD
    Ann Thorac Surg; 2013 Apr; 95(4):1262-7; discussion 1267-8. PubMed ID: 23063192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience with sternotomy versus subcostal approach for exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Gregoric ID; Bruckner BA; Jacob L; Kar B; Cohn WE; La Francesca S; Frazier OH
    Ann Thorac Surg; 2008 May; 85(5):1646-9. PubMed ID: 18442556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of Body Mass Index to Outcomes in Patients With Heart Failure Implanted With Left Ventricular Assist Devices.
    Galand V; Flécher E; Lelong B; Chabanne C; Charton M; Goéminne C; Vincentelli A; Porterie J; Delmas C; Nubret K; Pernot M; Kindo M; Hoang Minh T; Gaudard P; Rouvière P; Sénage T; Michel M; Boignard A; Chavanon O; Verdonk C; Para M; Pelcé E; Gariboldi V; Pozzi M; Obadia JF; Litzler PY; Anselme F; Blanchart K; Babatasi G; Garnier F; Bielefeld M; Radu C; Hamon D; Bourguignon T; Genet T; Eschalier R; D'Ostrevy N; Bories MC; Varlet E; Vanhuyse F; Sadoul N; Leclercq C; Martins RP
    Am J Cardiol; 2020 Oct; 133():81-88. PubMed ID: 32861423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A single center experience with the HeartMate II left ventricular assist device (LVAD).
    Granfeldt H; Peterzén B; Hübbert L; Jansson K; Ahn H
    Scand Cardiovasc J; 2009 Dec; 43(6):360-5. PubMed ID: 19544221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential impact on post-transplant outcomes between pulsatile- and continuous-flow left ventricular assist devices.
    Ventura PA; Alharethi R; Budge D; Reid BB; Horne BD; Mason NO; Stoker S; Caine WT; Rasmusson B; Doty J; Clayson SE; Kfoury AG
    Clin Transplant; 2011; 25(4):E390-5. PubMed ID: 21401721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Durable left ventricular assist device implantation in extremely obese heart failure patients.
    Lee AY; Tecson KM; Lima B; Shaikh AF; Collier J; Still S; Baxter R; DiMaio JM; Felius J; Carey SA; Gonzalez-Stawinski GV; Nauret R; Wong M; Hall SA; Joseph SM
    Artif Organs; 2019 Mar; 43(3):234-241. PubMed ID: 30357882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
    Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
    N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.